Oral anti-oxidant use for male partners of couples undergoing fertility treatments

Show simple item record

dc.contributor.author Showell, MG en
dc.contributor.author Brown, J en
dc.contributor.author Yazdani, A en
dc.contributor.author Stankiewicz, MT en
dc.contributor.author Hart, RJ en
dc.coverage.spatial Rome, ITALY en
dc.date.accessioned 2011-11-08T00:50:26Z en
dc.date.available 2011-11-08T00:50:26Z en
dc.date.issued 2010 en
dc.identifier.citation 26th Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology, Rome, ITALY, 27 Jun 2010 - 30 Jun 2010. HUMAN REPRODUCTION. OXFORD UNIV PRESS. 25. Jun 2010 en
dc.identifier.issn 0268-1161 en
dc.identifier.uri http://hdl.handle.net/2292/8811 en
dc.description.abstract Introduction: Between 30%-80% of male subfertility cases are considered to be due to the damaging effects of oxidative stress on sperm. Oral supplementation with antioxidants may improve sperm quality by reducing oxidative stress. This Cochrane review aimed to evaluate the effect of oral supplementation with antioxidants on male partners of couples attending a fertility clinic. Materials and Methods: All RCTs of oral antioxidant supplements in men were searched in the following sources: the Cochrane Menstrual Disorders and Subfertility Group Register, MEDLINE, CENTRAL, EMBASE, CINAHL, PSYCINFO and AMED databases (from their inception until January 2010), trial registers, unpublished literature, reference lists and experts in the field. RCTs comparing any type or dose of antioxidant (single or combined) versus placebo, no treatment or another antioxidant that were taken by the male partner of a couple seeking fertility assistance were included. The outcomes were live birth, pregnancy, miscarriage, or spontaneous abortion, stillbirth, level of sperm DNA damage, sperm motility, sperm concentration and adverse effects. We performed statistical meta-analyses in accordance with the guidelines developed by The Cochrane Collaboration for the effect of antioxidant/s versus placebo per couple randomised. Results: Fifty trials were considered and 32 met the inclusion criteria. 2696 couples in total. en
dc.publisher OXFORD UNIV PRESS en
dc.relation.ispartof 26th Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology en
dc.relation.ispartofseries HUMAN REPRODUCTION en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.source.uri http://dx.doi.org/10.1093/humrep/de.25.s1.001 en
dc.title Oral anti-oxidant use for male partners of couples undergoing fertility treatments en
dc.type Conference Item en
pubs.begin-page I119 en
pubs.volume 25 en
dc.rights.holder Copyright:OXFORD UNIV PRESS en
pubs.end-page I120 en
pubs.finish-date 30-06-2010 en
pubs.start-date 27-06-2010 en
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.elements-id 287563 en
pubs.org-id Faculty of Medical & Hlth Sci en
pubs.org-id School of Medicine en
pubs.org-id Obstetrics & Gynaecology Dept en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics